InsidersTradesSigma
Follow the 압타머사이언스 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 압타머사이언스 has logged 3 reports. Market capitalisation: €58bn. The latest transaction was reported on 22 April 2026 (Purchase). Among the most active insiders: Wellnew&Co.. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
Aptamer Science is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing aptamer-based therapies for various diseases.